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To demonstrate that pandemic (H1N1) 2009 virus may 
cause respiratory disease in cats, we intratracheally infect-
ed cats. Diffuse alveolar damage developed. Seroconver-
sion of sentinel cats indicated cat-to-cat virus transmission. 
Unlike in cats infected with highly pathogenic avian influ-
enza virus (H5N1), extrarespiratory lesions did not develop 
in cats infected with pandemic (H1N1) 2009 virus.
S
oon  after  pandemic  (H1N1)  2009  virus  emerged  in 
North America, infections in domestic cats were re-
ported (1,2). Infection with highly pathogenic avian influ-
enza (HPAI) virus (H5N1) leads to severe and often fatal 
diffuse alveolar damage and systemic virus spread in cats 
(3–5). In contrast, seasonal human influenza viruses do not 
cause disease in cats (6). To elucidate the pathogenesis of 
pandemic (H1N1) 2009 virus infection in cats, we studied 8 
laboratory cats intratracheally infected with this virus.
The Study
Pandemic  (H1N1)  2009  virus  (A/Netherlands/602/ 
2009) was isolated from a 3-year-old girl from the Neth-
erlands who had mild influenza after she visited Mexico 
in early 2009. Virus was cultured in embryonated chicken 
eggs and passaged once in MDCK cells (7).
We  used  2  groups  (4  cats/group)  of  16-week-old, 
purpose-bred, specific pathogen–free, European shorthair 
cats that were seronegative for hemagglutination-inhibi-
tion (HI) antibodies against pandemic (H1N1) 2009 virus 
and circulating seasonal influenza A viruses. These cats 
were intratracheally infected with a 106.0 tissue culture in-
fectious dose (TCID50) of pandemic (H1N1) 2009 virus. 
A third group of 3 sentinel cats were housed with these 2 
infected groups (1 with group 1 and 2 with group 2) from 
2 days postinfection (dpi) onward. Serum samples were 
obtained on 0, 4, 7, and 21 dpi and stored at –20°C until 
tested for HI antibodies against pandemic (H1N1) 2009 
virus (8).
 All 11 cats were monitored daily for clinical signs, and 
body temperature was measured at 15-min intervals. Nasal, 
pharyngeal, and rectal swab specimens were obtained daily 
from all cats. After being anesthetized with ketamine, all 
cats were killed by exsanguination. Cats in groups 1 and 
2 were killed at 4 dpi and 7 dpi, respectively. Sentinel cats 
were killed at 21 dpi. Experiments were performed under 
BioSafety Level 3 by using protocols approved by our In-
stitutional Animal Welfare Committee.
Necropsies were performed according to a standard 
protocol. Lung, nasal turbinate, nasal septum, larynx, tra-
chea, bronchus, tracheobronchial lymph node, nictitating 
membrane,  tonsil,  heart,  liver,  spleen,  kidney,  pancreas, 
duodenum, jejunum, colon, adrenal gland, brain, and olfac-
tory bulb samples were obtained, were fixed in formalin, 
and processed to obtain sections for staining with hema-
toxylin and eosin.
For  detection  of  viral  antigen,  tissue  sections  were 
stained with viral nucleoprotein–specific antibody (6). Al-
veolar epithelial cells were phenotyped by using a destain-
ing–restaining  technique  (9).  After  organ  samples  were 
weighed and stored at –80°C, infectious pandemic (H1N1) 
2009 virus was quantified by limiting dilution virus isola-
tion in MDCK cells (10).
Cats in groups 1 and 2 infected with pandemic (H1N1) 
2009 virus showed mild-to-moderate clinical signs (leth-
argy, appetite loss, rapid and labored breathing, and pro-
truding nictitating membrane) after 1 dpi or 2 dpi onwards. 
Average body temperatures increased after 1 dpi, showed 
a maximum increase of ≈1.5°C by 2 dpi, and returned to 
baseline  values  within  4–5  dpi  (Figure).  Sentinel  cats 
showed no clinical signs. Two cats in group 1 (2 pharyn-
geal samples) and 2 cats in group 1 and 1 cat in group 2 
(1 pharyngeal sample) had low virus titers during 1–4 dpi 
(<101.8 TCID50/g). Nasal swab specimens from all sentinel 
cats and pharyngeal and rectal swab specimens from 2 were 
virus positive by reverse transcription–PCR (cycle thresh-
old >35) 2–6 days after first contact with infected cats. No 
virus was isolated from these swab specimens.
On 4 dpi, high virus titers were found in lungs, bron-
chi, and tracheas from 4 infected cats (105.5–6.3, 102.9–4.6, and 
103.1–3.8 TCID50/g, respectively). Tonsils from 2 cats, intes-
tines from 1 cat, and the spleen from 1 cat also had high 
virus titers (103.0, 104.2, 101.6, and 101.6 TCID50/g, respec-
tively). On 7 dpi, virus was detected in lung from 1 cat and 
trachea from 1 cat (103.0 and 101.6 TCID50/g, respectively). 
Infectious virus (101.2–2.2 TCID50/g) was found in liver, in-
testine, brain, adrenal glands, and nictitating membranes of 
individual cats. The olfactory bulb of 1 cat was virus posi-
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No serum HI antibodies (titer <20) were found in group 
1 cats on 4 dpi. All group 2 cats had serum HI antibodies 
(titers 30–120) on 7 dpi. One sentinel cat was seropositive 
on 15 dpi (titer 40); all cats were positive on 21 dpi (titer 
80).
All infected cats showed multifocal or coalescing pul-
monary consolidation, ranging from 30% to 50% on 4 dpi 
and from 10% to 30% on 7 dpi (online Technical Appen-
dix,  www.cdc.gov/EID/content/16/11/1746-Techapp.pdf). 
All  tracheobronchial  lymph  nodes  were  enlarged  3–5×. 
Palatine tonsils were enlarged ≈2× on 7 dpi. All sentinel 
cats  showed  mild  multifocal  consolidation;  5%–10%  of 
lung parenchyma were affected. Two cats had tracheobron-
chial lymph nodes enlarged 2–5×.
Histopathologic analysis (online Technical Appendix) 
identified pulmonary consolidation indicative of diffuse al-
veolar damage. Alveolar and bronchiolar lumina showed 
edema and contained variable numbers of macrophages, 
neutrophils, and erythrocytes mixed with fibrin and cellular 
debris. Alveolar walls were thickened and showed necrosis 
of lining epithelium and type II pneumocyte hyperplasia.
Bronchiolar walls were moderately infiltrated by neu-
trophils and had multifocal epithelial necrosis and multifo-
cal peribronchiolar moderate infiltration by macrophages 
and  lymphocytes  and  few  neutrophils  and  plasmacytes. 
Bronchial  lumina  harbored  few  neutrophils  and  scant 
edema, fibrin, and cellular debris. There were few peri-
bronchial infiltrates with a small number of lymphocytes, 
plasmacytes,  and  macrophages.  Lung  lesions  seen  on  4 
dpi and 7 dpi were comparable except for more extensive 
type II pneumocyte hyperplasia on 7 dpi. Tracheobronchial 
lymph nodes and palatine tonsils had severe sinus histio-
cytosis and lymphocytolysis and moderate infiltration by 
neutrophils. Histologic changes in lung parenchyma of all 
sentinel cats were consistent with chronic lesions resulting 
from those seen in the other cats. No lesions were seen in 
other organs of all cats.
Virus antigen expression was more prominent on 4 dpi 
than on 7 dpi and was closely associated with histologic 
lesions  (online  Technical  Appendix).  Virus  antigen  ex-
pression was seen in many type II pneumocytes, few type 
I pneumocytes, alveolar macrophages, bronchiolar ciliated 
and nonciliated epithelial cells, and rare bronchial ciliated 
epithelial cells. Type I and II pneumocytes were identified 
by double-staining with cytokeratin. No virus antigen was 
observed in sentinel cats.
Conclusions
Intratracheal infection of domestic cats with pandemic 
(H1N1) 2009 virus resulted in mild-to-moderate clinical 
signs and virus replication throughout the respiratory tract, 
which caused diffuse alveolar damage. The pathogenesis in 
the respiratory tract in cats was similar to that occurring in 
humans, macaques, and ferrets (7,11–13). Seroconversion 
of sentinel cats indicated cat-to-cat transmission.
Unlike  infection  with  seasonal  human  influenza  vi-
ruses, infection with pandemic (H1N1) 2009 virus causes 
respiratory  disease  in  cats.  To  compare  infections  with 
these viruses, we used our unpublished data for cats intra-
tracheally infected with 105.0 TCID50 of HPAI virus (H5N1) 
(A/Indonesia/5/2005) at 4 dpi and 7 dpi (4) and for sham-
infected cats. Histopathologic and immunohistochemical 
findings in lungs of cats infected with these viruses coin-
cided, which indicated a similar pathogenetic process and 
increased severity in cats infected with HPAI virus (H5N1). 
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Figure.  Average  body  temperatures  of  2  groups  of  cats 
experimentally infected with pandemic (H1N1) 2009 virus (groups 
1 and 2) and sentinel cats (group 3).
Table. Test results for 8 cats intratracheally infected with 
pandemic (H1N1) 2009 virus*  
Tissue source 
No. positive 
IHC analysis  Virus isolation† 
4 dpi 7 dpi 4 dpi 7 dpi
Respiratory 
  Lung  4 3 4 1
  Bronchus  2 0 4 0
  Trachea  0 0 4 1
  Nasal turbinates  0 0 2 0
Extrarespiratory 
  Liver  0 0 0 1
  Intestine  0 0 1 1
  Olfactory bulb  0 0 0 1
  Brain  0 0 0 1
  Spleen  0 0 1 0
  Tonsil  0 0 2 0
  Adrenal gland  0 0 0 2
  Nictitating membrane  0 0 0 2
*Four cats were examined on each day. IHC, immunohistochemical; dpi, 
days postinfection. 
†No virus was isolated from tracheobronchial lymph node, pancreas, 
heart, or kidney of any cats. Pandemic (H1N1) 2009 Virus and Cats
However,  in  contrast  to  HPAI  virus  (H5N1),  pandemic 
(H1N1) 2009 virus does not cause extrapulmonary lesions 
in infected cats. Our data show that pandemic (H1N1) 2009 
virus may cause respiratory disease in cats and that human-
to-cat transmission is the most likely route of infection.
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